Together, our findings uncover a role of adipose tissue NAPE-PLD on whole-body metabolism and provide support for targeting NAPE-PLD-derived bioactive lipids to treat obesity and related metabolic disorders. Here, GPLD1 is linked to obesity due to melanocortin 4 receptor deficiency.